îæ€çŽ¢
îæ€çŽ¢
î
Lexaria Bioscience Corp
LEXXîãŠã©ãããªã¹ãã«è¿œå
3.080USD
+0.090+3.01%
çµå€Â 10-22 16:00ïŒETïŒ
6.50Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Lexaria Bioscience CorpïŒLEXXïŒç®æšæ ªäŸ¡ïŒèŠéã
ç®æšæ ªäŸ¡
52.500USD+1735.66%
LEXX ã¢ããªã¹ãæšå¥šãã¬ã³ã
ä»æãLEXXã¯0件ã®ãè²·ããã0件ã®ãäžç«ïŒããŒã«ãïŒãã0件ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããLEXXã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯52.500ã§ãã
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
LEXX åæ¥è æ¯èŒã¢ããªã¹ãè©äŸ¡
æŽæ°æå»: Oct 20, 2026äŒç€Ÿå
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ã¢ããªã¹ã
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
財åäºæž¬
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -1.204ã«ç¶ããLEXXã®FY2026Q4ã®EPSã¯-0.900ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
äºæž¬å€
-1.95
-1.43
-1.27
-0.90
å®çžŸå€
-1.12
-0.06
-1.20
--
ãµãã©ã€ãº
+42.60%
+95.84%
+5.56%
--
ãããã質å
Lexaria Bioscience Corp ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãLexaria Bioscience Corp ã®ç®æšæ ªäŸ¡ã USD 52.50 ãšäºæ³ããæé«äºæ³ã¯ USD 82.50ãæäœäºæ³ã¯ USD 22.50 ãšäºæ³ããŠããŸãã
Lexaria Bioscience CorpLEXX ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -1.20 ã§ããããLexaria Bioscience CorpLEXX ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.06 ã§ããã次ã®ååæã® EPS 㯠USD -0.90 ãšäºæ³ãããŸãã